BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 26752561)

  • 1. Proteomics Based Identification of Proteins with Deregulated Expression in B Cell Lymphomas.
    Wu R; Nijland M; Rutgers B; Veenstra R; Langendonk M; van der Meeren LE; Kluin PM; Li G; Diepstra A; Chiu JF; van den Berg A; Visser L
    PLoS One; 2016; 11(1):e0146624. PubMed ID: 26752561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
    Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
    J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global phosphoproteomic profiling reveals distinct signatures in B-cell non-Hodgkin lymphomas.
    Rolland D; Basrur V; Conlon K; Wolfe T; Fermin D; Nesvizhskii AI; Lim MS; Elenitoba-Johnson KS
    Am J Pathol; 2014 May; 184(5):1331-42. PubMed ID: 24667141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programmed death ligand 1 is expressed by non-hodgkin lymphomas and inhibits the activity of tumor-associated T cells.
    Andorsky DJ; Yamada RE; Said J; Pinkus GS; Betting DJ; Timmerman JM
    Clin Cancer Res; 2011 Jul; 17(13):4232-44. PubMed ID: 21540239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic-Based Analysis of Hypoxia- and Physioxia-Responsive Proteins and Pathways in Diffuse Large B-Cell Lymphoma.
    Duś-Szachniewicz K; Gdesz-Birula K; Zduniak K; Wiśniewski JR
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surfaceome of classical Hodgkin and non-Hodgkin lymphoma.
    Hofmann A; Thiesler T; Gerrits B; Behnke S; Sobotzki N; Omasits U; Bausch-Fluck D; Bock T; Aebersold R; Moch H; Tinguely M; Wollscheid B
    Proteomics Clin Appl; 2015 Aug; 9(7-8):661-70. PubMed ID: 26076441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma.
    Shi H; Guo J; Duff DJ; Rahmatpanah F; Chitima-Matsiga R; Al-Kuhlani M; Taylor KH; Sjahputera O; Andreski M; Wooldridge JE; Caldwell CW
    Carcinogenesis; 2007 Jan; 28(1):60-70. PubMed ID: 16774933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deepening into Intracellular Signaling Landscape through Integrative Spatial Proteomics and Transcriptomics in a Lymphoma Model.
    Landeira-Viñuela A; Díez P; Juanes-Velasco P; Lécrevisse Q; Orfao A; De Las Rivas J; Fuentes M
    Biomolecules; 2021 Nov; 11(12):. PubMed ID: 34944421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein expression pattern distinguishes different lymphoid neoplasms.
    Fujii K; Kondo T; Yokoo H; Yamada T; Matsuno Y; Iwatsuki K; Hirohashi S
    Proteomics; 2005 Nov; 5(16):4274-86. PubMed ID: 16206328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of the human MIXL1 gene product in non-Hodgkin and Hodgkin lymphomas.
    Drakos E; Rassidakis GZ; Leventaki V; Guo W; Medeiros LJ; Nagarajan L
    Hum Pathol; 2007 Mar; 38(3):500-7. PubMed ID: 17303500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma.
    Chaganti SR; Chen W; Parsa N; Offit K; Louie DC; Dalla-Favera R; Chaganti RS
    Genes Chromosomes Cancer; 1998 Dec; 23(4):323-7. PubMed ID: 9824205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. State of the Art and Future Needs in Cytogenetic/Molecular Genetics/Arrays in childhood lymphoma: summary report of workshop at the First International Symposium on childhood and adolescent non-Hodgkin lymphoma, April 9, 2003, New York City, NY.
    Heerema NA; Bernheim A; Lim MS; Look AT; Pasqualucci L; Raetz E; Sanger WG; Cairo MS
    Pediatr Blood Cancer; 2005 Oct; 45(5):616-22. PubMed ID: 16127683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hidden gene amplifications in aggressive B-cell non-Hodgkin lymphomas detected by microarray-based comparative genomic hybridization.
    Wessendorf S; Schwaenen C; Kohlhammer H; Kienle D; Wrobel G; Barth TF; Nessling M; Möller P; Döhner H; Lichter P; Bentz M
    Oncogene; 2003 Mar; 22(9):1425-9. PubMed ID: 12618769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of markers associated with highly aggressive metastatic phenotypes using quantitative comparative proteomics.
    Terp MG; Lund RR; Jensen ON; Leth-Larsen R; Ditzel HJ
    Cancer Genomics Proteomics; 2012; 9(5):265-73. PubMed ID: 22990106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of Proteomics and Transcriptomics Data Sets for the Analysis of a Lymphoma B-Cell Line in the Context of the Chromosome-Centric Human Proteome Project.
    Díez P; Droste C; Dégano RM; González-Muñoz M; Ibarrola N; Pérez-Andrés M; Garin-Muga A; Segura V; Marko-Varga G; LaBaer J; Orfao A; Corrales FJ; De Las Rivas J; Fuentes M
    J Proteome Res; 2015 Sep; 14(9):3530-40. PubMed ID: 26216070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncoprotein MDM2 overexpression is associated with poor prognosis in distinct non-Hodgkin's lymphoma entities.
    Møller MB; Nielsen O; Pedersen NT
    Mod Pathol; 1999 Nov; 12(11):1010-6. PubMed ID: 10574597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCL-6 expression in reactive lymphoid tissue and in B-cell non-Hodgkin's lymphomas.
    Pittaluga S; Ayoubi TA; Wlodarska I; Stul M; Cassiman JJ; Mecucci C; Van Den Berghe H; Van De Ven WJ; De Wolf-Peeters C
    J Pathol; 1996 Jun; 179(2):145-50. PubMed ID: 8758205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significantly different bcl-2 expression profiles in gastric and non-gastric primary extranodal high-grade B-cell lymphomas.
    Cogliatti SB; Griesser H; Peng H; Du MQ; Isaacson PG; Zimmermann DR; Maibach RC; Schmid U
    J Pathol; 2000 Dec; 192(4):470-8. PubMed ID: 11113864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteins upregulated by mild and severe hypoxia in squamous cell carcinomas in vitro identified by proteomics.
    Sørensen BS; Horsman MR; Vorum H; Honoré B; Overgaard J; Alsner J
    Radiother Oncol; 2009 Sep; 92(3):443-9. PubMed ID: 19541378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of inhibitor of apoptosis proteins in B-cell non-Hodgkin and Hodgkin lymphomas.
    Akyurek N; Ren Y; Rassidakis GZ; Schlette EJ; Medeiros LJ
    Cancer; 2006 Oct; 107(8):1844-51. PubMed ID: 16983704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.